Filing Details
- Accession Number:
- 0001209191-19-039454
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-28 15:25:26
- Reporting Period:
- 2019-06-28
- Accepted Time:
- 2019-06-28 15:25:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1566373 | Spring Bank Pharmaceuticals Inc. | SBPH | Pharmaceutical Preparations (2834) | 522386345 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1614975 | Andrew Scott Smith | C/O Spring Bank Pharmaceuticals, Inc. 35 Parkwood Drive Hopkinton MA 01748 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-06-28 | 12,000 | $4.09 | 13,883 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $3.94 to $4.10 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
